Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy

Maria Di Cicco; Ester Del Tufo; Eva Parolo; Mariacristina Menconi; Sayla Bernasconi; Chiara Romei; Alessandro Di Gangi; Beatrice Masini; Diego Peroni; Gabriella Casazza

doi:10.1183/23120541.00407-2021

Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy

ERJ Open Res. 2021 Sep 20;7(3):00407-2021. doi: 10.1183/23120541.00407-2021. eCollection 2021 Jul.

Affiliations

¹ Dept of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy.
² Pediatric Onco-haematology Unit, Pisa University Hospital, Pisa, Italy.
³ Dept of Diagnostic Imaging, 2nd Radiology Unit, Pisa University Hospital, Pisa, Italy.

Abstract

Ruxolitinib could be considered as an option in the treatment of LONIPCs in children when other treatments are ineffective. Spirometry is a valuable tool for both diagnosis and follow-up of LONIPCs in children. https://bit.ly/3BmOYfb.